Direct medical costs associated with different lines of therapy for colorectal cancer patients

By Ray Saurabh   Bonthapally Vijayveer   Meyer Nicole M   Miller Jeffrey D   Bonafede Machaon M   Curkendall Suellen M  

Colorectal Cancer, Vol. 2, Iss. 2, 2013-04 ,pp. : 121-134

Future Medicine

Access to resources Recommend Favorite

Chromosomal imbalances associated with acquired resistance to fluoropyrimidines in human colorectal cancer cells

By Hidaka S.   Yasutake T.   Fukushima M.   Yano H.   Haseba M.   Tsuji T.   Sawai T.   Yamaguchi H.   Nakagoe T.   Ayabe H.   Tagawa Y.  

European Journal of Cancer, Vol. 39, Iss. 7, 2003-05 ,pp. : 975-980

Elsevier

Access to resources Recommend Favorite

Comparison of human gut microbiota in control subjects and patients with colorectal carcinoma in adenoma: Terminal restriction fragment length polymorphism and next-generation sequencing analyses

By                      

Oncology Reports, Vol. 35, Iss. 1, 2016-01 ,pp. : 325-333

Spandidos Publications

Access to resources Recommend Favorite

Chemokine expression is associated with the accumulation of tumour associated macrophages (TAMs) and progression in human colorectal cancer

By Bailey Charles   Negus Rupert   Morris Alistair   Ziprin Paul   Goldin Robert   Allavena Paola   Peck David   Darzi Ara  

Clinical and Experimental Metastasis, Vol. 24, Iss. 2, 2007-04 ,pp. : 121-130

Springer Publishing Company

Access to resources Recommend Favorite

Immunoblot analysis of c-Met expression in human colorectal cancer: Overexpression is associated with advanced stage cancer

By Zeng Zhaoshi   Weiser Martin   D’Alessio Matt   Grace Andrew   Shia Jinru   Paty Philip  

Clinical and Experimental Metastasis, Vol. 21, Iss. 5, 2004-12 ,pp. : 409-417

Springer Publishing Company

Access to resources Recommend Favorite